Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization and Application of Ischemic Stroke Secondary Prevention Programs
ChiCTR-IPR-16008043Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butylphthalide in ischemic stroke (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Ratio of drug applying in stroke secondary prevention, Risk factors treatment success rate and 2 more. Started Apr 2012; status: completed.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-IPR-16008043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008043.